Blood Cancer Taskforce | Leukaemia Foundation

Blood Cancer Taskforce

Some of the taskforce members including (from L-R): Professor Andrew Roberts, Deborah Sims, Dr Delaine Smith and Bill Petch.

The Leukaemia Foundation has established the Blood Cancer Taskforce to help us develop Australia’s First National Strategic Action Plan for Blood Cancer.  

The Blood Cancer Taskforce unites Australia’s leading haematologists, researchers, patients and members of the blood cancer ecosystem together for the first time, to provide the blueprint to help tackle the key issues facing the blood cancer community today and into the future. 

The Taskforce is co-Chaired by Bill Petch, CEO, Leukaemia Foundation and Professor John Seymour, Director of Cancer Medicine, Clinical Research and Haematology, Peter MacCallum Centre. A full list of members can be found below.  

The formation of the Taskforce and development of the National Strategic Action Plan together mark a major milestone for the blood cancer community and will set the national agenda around blood cancer for many years to come.  

The Taskforce will meet for the first time at the end of September 2019 and will work together to develop the Action Plan, which will be delivered to Government by June 2020. 

Taskforce members

NamePositionRepresenting
Professor Sanchia Aranda AM   CEOCancer Council Australia  
Dr John BashfordDirector of ResearchIcon Group & PCPA 
Dr Joe Collins RepresentativeLions Club Interational
Dr Chris Fraser Chair Executive Council   ANZCHOG
Professor Maher Gandhi CEO and Director of Clinical Research Mater Research  
Professor David Gottlieb Program Director BMT, Head Cell Therapies   Westmead Hospital  
Barbie Hartigan   Advocate   Leukaemia Foundation Patient Support  
Professor Tim Hughes   Cancer Theme Leader   SAHMRI  
Dr Paul Jackson   General Manager Knowledge Management   Cancer Australia  
Professor David Joske   Chairperson   Solaris Cancer Care  
Melanie Kelly   Director   Insight Economics  
Dr Rishi Kotecha Consultant Paediatric Oncologist & Clinical Haematologist Perth Children’s Hospital; ANZCHOG
A/Professor Steven Lane   Head of Cancer Program   QIMR Berghofer  
A/Professor Peter Mollee   Director  Australasian Leukaemia & Lymphoma Group  
Bill Petch  CEO  Leukaemia Foundation 
Professor Miles Prince AM Director, Centre for Blood Cell Therapies Director of Molecular Oncology and Cancer Immunology Epworth   Peter MacCallum Cancer Centre ; Snowdome Foundation; Myeloma Australia
Professor Andrew Roberts   Laboratory Head; Joint Leader, Cancer Research and Treatments Theme   Walter and Eliza Hall Institute  
Professor John Seymour   Director: Cancer Medicine; Director: Department of Haematology   Peter MacCallum Cancer Centre  
Deborah Sims   Patient and advocate   Blood Cancer Survivor  
Dr Delaine Smith   CEO   Australasian Leukaemia & Lymphoma Group  
Elizabeth de Somer   CEOMedicines Australia
Dr Will Stevenson   President   Haematology Society of Australia & New Zealand  
Richard Vines   Chairman   Rare Cancers Australia  
Posted on September 2nd, 2019

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.

Share this page

X
X